EXEL
Exelixis, Inc. · Healthcare
Director Sue Gail Eckhardt sold $169K of Exelixis, Inc.
Sold$168,854
$43.79Price
3,856Shares
−18%Stake
What EXEL did after the filing
- The stock from Wed, Feb 18 close, $44.47
- −1.0%
- S&P 500, same days
- −4.5%
Measured over 30 trading days, to the Apr 1 close.
Traded Fri, Feb 13. Filed Wed, Feb 18, 3:49 PM ET, during the session. Returns use the Feb 18 close and the Apr 1 close. Not investment advice.